The master's thesis deals with the determination of estimated market value of the pharmaceutical company Novartis Ltd. based on publicly available information for the needs of the owner and management. The estimated value of company refers to December 31, 2011. For this purpose, first, it is necessary to do a development analysis of macroeconomic indicators in the Czech market and analysis of pharmaceutical industry. In addition, the subsidiary company of Swiss group, but necessary also parent company as its the most "business partner" are presented. It is followed by financial analysis of the subsidiary branch Novartis Ltd., prognosis of value drivers, financial plan. In the final part of thesis, on the basic of the financial plan and assumption of company's continued existence, the value of company is determined, using discount methods with free cash flow to the equity.
Identifer | oai:union.ndltd.org:nusl.cz/oai:invenio.nusl.cz:125195 |
Date | January 2011 |
Creators | Glovňová, Paulína |
Contributors | Kislingerová, Eva, Smrčka, Luboš |
Publisher | Vysoká škola ekonomická v Praze |
Source Sets | Czech ETDs |
Language | Slovak |
Detected Language | English |
Type | info:eu-repo/semantics/masterThesis |
Rights | info:eu-repo/semantics/restrictedAccess |
Page generated in 0.0016 seconds